Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01218828 · ClinicalTrials.gov registry record · Phase 3
Prevention of Contrast Renal Injury With Different Hydration Strategies
A Phase 3 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 396
- Enrollment target
NCT01218828 is a Phase 3 study that has completed, run by Kaiser Permanente. The registered enrollment target is 396 participants.
The verdict
NCT01218828, a Phase 3 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 396 participants
- Enrollment target
Study Summary
Using a randomized controlled trial design, two hydration protocols for the prevention of contrast medium-induced nephropathy will be tested.
Interventions
- OTHER LVEDP -Based hydration strategy
- OTHER Standard hydration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01218828
The ClinicalTrials.gov registry entry for NCT01218828 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 396 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LVEDP -Based hydration strategy is the first listed.
NCT01218828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01218828 about?
NCT01218828 is a clinical study titled "Prevention of Contrast Renal Injury With Different Hydration Strategies". Using a randomized controlled trial design, two hydration protocols for the prevention of contrast medium-induced nephropathy will be tested.
What is the current status of trial NCT01218828?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 396 participants. The study started on 2010-10. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01218828?
The interventions under investigation include: LVEDP -Based hydration strategy (OTHER), Standard hydration (OTHER).
Who is sponsoring clinical trial NCT01218828?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.